41
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

To boost or not to boost? The long-term protection of people vaccinated in infancy from the perspective of the healthcare worker

Pages 678-680 | Received 31 May 2020, Accepted 03 Jun 2020, Published online: 17 Jun 2020

References

  • Hess L, Riesenberg K, Rolston KVI, et al. Administrating an additional hepatitis B vaccination dose after 18 years maintains adequate long-term protection levels in healthcare workers. Infect Dis. 2020;52(5):330–335.
  • Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53(1):68–75.
  • Van Damme P. Long-term protection after hepatitis B vaccine. J Infect Dis. 2016;214(1):1–3.
  • Wang Z-Z, Gao Y-H, Lu W, et al. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China. Hum Vaccin Immunother. 2017;13(4):909–915.
  • Coppola N, Corvino AR, De Pascalis S, et al. The long-term immunogenicity of recombinant hepatitis B virus (HVC) vaccine: contribution of universal HBV vaccination in Italy. BMC Infect Dis. 2015;15(1):149.
  • Meireles LC, Marinho RT, Van Damme P. Three decades of hepatitis B control with vaccination. World J Hepatol. 2015;7(18):2127–2132.
  • John TJ, Cooksley G. Steering Committee for the Prevention and Control of Infectious Diseases in Asia. Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations? J Gastroenterol Hepatol. 2005;20(1):5–10.
  • Bruce MG, Bruden D, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016;214(1):16–22.
  • Anderson CL, Remschmidt C, Drobnitzky F-P, et al. Hepatitis B immune status in adolescents vaccinated during infancy: a retrospective cohort study from a pediatric practice in Germany. Hum Vacc Immunother. 2016;12(3):779–784.
  • Poorolajal J, Hooshmand E. Booster dose vaccination for preventing hepatitis B. Cochrane Syst Rev. 2016;2016(6):CD008256.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.